# New clinical trials in Israel: 688 since Nov 2024

Updated November 6, 2026.

688 clinical studies with a site in Israel were first posted on ClinicalTrials.gov from November 12, 2024 to November 6, 2026; 345 have an industry sponsor and 516 are recruiting or about to. The newest, NCT07923149, was posted on November 6, 2026: Split-Belt Treadmill Training to Improve Walking After Hip Fracture (Israel Dudkiewicz).

## The full list

New clinical trials with a site in Israel: 688 rows for $34.40, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Enrollment, Enrollment type, Location countries, Central contact, Contact phone, Contact email, Last update posted, Read on, Source. The new rows each week by email, about 23 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/country/israel

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

- New trials: 688
- Industry sponsored: 345
- Recruiting or not yet: 516
- Latest posted: November 6, 2026

## Newest trials

The newest 100 of 688, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Countries | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 6, 2026 | NCT07923149 | Split-Belt Treadmill Training to Improve Walking After Hip Fracture | Israel Dudkiewicz | Not applicable | Completed | Hip Fracture | 24 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07923149) |
| November 6, 2026 | NCT07920913 | Concomitant Fibromyalgia and Psychiatric Disorders | Sergio Gabriel Susmallian | Observational | Completed | Fibromyalgia (FM), Depression | 56,716 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07920913) |
| November 5, 2026 | NCT07919015 | Real-world Study of Nerandomilast in Patients With Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis | Avraham Unterman | Observational | Recruiting | Idiopathic Pulmonary Fibrosis (IPF), Progressive Pulmonary Fibrosis | 70 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07919015) |
| November 4, 2026 | NCT07915219 | A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON) | Boehringer Ingelheim | Phase 3 | Not yet recruiting | Bronchiectasis | 1,500 | Argentina, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China, Czechia... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07915219) |
| November 3, 2026 | NCT07913529 | Time Course of Clozapine-associated Agranulocytosis Over 19 Years | Sheba Medical Center | Observational | Completed | Agranulocytosis, Neutropenia, SCHIZOPHRENIA 1 (Disorder), Treatment-resistant Schizophrenia | 2,020 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07913529) |
| November 3, 2026 | NCT07913425 | Examining the Effectiveness of a Brief Therapeutic Intervention for Reducing Self-Harm Among Adolescents | University of Haifa | Not applicable | Not yet recruiting | Self Injurious Behavior, Self Injurious Behavior Without Suicidal Intent | 40 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07913425) |
| November 3, 2026 | NCT07913386 | Rigid Hymenal Ring as a Cause for Insertional Dyspareunia | Hadassah Medical Organization | Observational | Recruiting | Dyspareunia (Female) | 200 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07913386) |
| November 3, 2026 | NCT07913152 | Heart@Home Safety and Efficacy of Hospital-at-Home Care Versus Standard Hospitalization in Cardiac Patients | Tel-Aviv Sourasky Medical Center | Not applicable | Recruiting | Myocardial Infarction, Myocarditis Acute, Pericarditis, Pulmonary Embolism Acute, Heart Failure Acute, Transcatheter... | 150 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07913152) |
| November 2, 2026 | NCT07911215 | Effects of Brief Heart Rate Variability Biofeedback on Physiological and Emotional Responses | University of Haifa | Not applicable | Completed | Autonomic Nervous System Function, Psychophysiological Regulation | 32 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07911215) |
| November 2, 2026 | NCT07910136 | Pre-Examination Reflexology for Anxiety and Pain During Pelvic Examination | Goni Sintov | Not applicable | Not yet recruiting | Anxiety | 120 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07910136) |
| November 2, 2026 | NCT07909382 | Multi-biomarkers in DEE | Istituto Giannina Gaslini | Observational | Recruiting | Developmental and Epileptic Encephalopathies (DEE) | 200 | Belgium, Denmark, France, Germany, Israel, Italy, Netherlands, Spain | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07909382) |
| October 30, 2026 | NCT07907770 | Perception of Action Opportunities for Obstacle Crossing in Parkinson's Disease | University of Haifa | Observational | Not yet recruiting | PARKINSON DISEASE (Disorder), Older Adults (65-85 Years) | 120 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07907770) |
| October 30, 2026 | NCT07906717 | A Study of JNJ-101556143 With Best Supportive Care in Participants With Metastatic Prostate Cancer | Janssen Research & Development, LLC | Phase 3 | Recruiting | Prostatic Neoplasms | 400 | Israel, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07906717) |
| October 28, 2026 | NCT07900412 | Evaluation of the Diagnostic Potential of Nanox.ARC Tomosynthesis System for Different Diseases | Nano-X Imaging | Not applicable | Recruiting | Fracture, Erosion | 100 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07900412) |
| October 27, 2026 | NCT07898033 | 1 Year Recurrence After Modified en Bloc Resection (ERBT) vs Transurethral Resection (TURBT) for Large Bladder Tumors | dmitry enikeev | Phase 3 | Recruiting | NMIBC, TCC | 136 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07898033) |
| October 26, 2026 | NCT07895160 | Organ Culture for Endocrine Resistant Next Line: A Treatment Selection Study in Metastatic Breast Cancer | Tel-Aviv Sourasky Medical Center | Not applicable | Recruiting | Metastatic Breast Cancer, Hormon Receptor Positive Breast Cancer | 39 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07895160) |
| October 26, 2026 | NCT07893483 | Safety, Tolerability, and Efficacy of Oral KM-023 in Adult Patients With Pachyonychia Congenita (pEDD-PC) | Orvida Pharma (formerly Kamari Pharma) | Phase 2 | Not yet recruiting | Pachyonychia Congenita | 10 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07893483) |
| October 23, 2026 | NCT07893119 | Effect of Voiding Position (Standing in the Shower vs. Sitting) on Post- Void Residual Urine Volume (PVR) After Removal of Urinary Catheter... | Assuta Ashdod Hospital | Not applicable | Not yet recruiting | Postpartum Urinary Retention | 100 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07893119) |
| October 23, 2026 | NCT07892677 | Methadone Administration in Critically Ill Patients in the Intensive Care Unit and Risk of Prolonged QTc and Cardiac Arrythmia | Meir Medical Center | Observational | Not yet recruiting | Patients Treated With Methadone | 300 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07892677) |
| October 19, 2026 | NCT07881666 | Inactivated UPEC-FimON for Non Muscle Invasive Bladder Cancer After BCG or Intravesical Chemotherapy Failure | Hopec Pharma | Phase 1 | Recruiting | Urinary Bladder Neoplasms | 30 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07881666) |
| October 19, 2026 | NCT07880340 | Deep TMS for PTSD With Suicidal Ideation | D.R. Rut Zaks OHAYON | Not applicable | Not yet recruiting | Post Traumatic Stress Disorder PTSD, Suicidal Ideation | 72 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07880340) |
| October 16, 2026 | NCT07879261 | Hazardous Substances Injuries | Sergio Gabriel Susmallian | Observational | Completed | Occupational Diseases | 1,951 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07879261) |
| October 16, 2026 | NCT07879040 | The Impact of Hyperbaric Oxygen Therapy on Vocal Performance in Professional Singers | Assaf-Harofeh Medical Center | Not applicable | Recruiting | Vocal Cord Strain (Disorder) | 70 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07879040) |
| October 16, 2026 | NCT07878637 | Foot Reflexology for Anxiety in Women Hospitalized With High-Risk Pregnancy | Wolfson Medical Center | Not applicable | Not yet recruiting | Anxiety, Pregnancy, High-Risk, Pregnancy Complications | 144 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07878637) |
| October 15, 2026 | NCT07875985 | Predictors of Successful Office Operative Hysteroscopy Using a Mini-Resectoscope | Shaare Zedek Medical Center | Observational | Not yet recruiting | Retained Products of Conception, Hysteroscopy, Endometrial Polyp Benign, Endometrial Polyp, Endometrial Polyps... | 50 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07875985) |
| October 14, 2026 | NCT07874334 | Phase 1a/b Study of GPRC5D CART Therapy in Relapsed/Refractory Multiple Myeloma and Light-chain Amyloidosis | Hadassah Medical Organization | Phase 1 | Not yet recruiting | Relapsed/Refractory Multiple Myeloma (RRMM), Light-Chain Amyloidosis | 160 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07874334) |
| October 13, 2026 | NCT07871799 | ELITE: Deep Profiling and Algorithmic Polytherapy to Map Individual Response in Healthy Aging | Sheba Medical Center | Phase 2 | Completed | Healthy Aging | 31 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07871799) |
| October 13, 2026 | NCT07869953 | Oftac Eye Drops (0.05% Tacrolimus Ophthalmic Emulsion) for the Treatment of Active Non-infectious Anterior Uveitis | BioNanoSim Ltd. | Phase 1/2 | Completed | Non-Infectious Anterior Uveitis | 18 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07869953) |
| October 9, 2026 | NCT07868861 | A Study to Compare the Bioavailability of Ondansetron Following Nasal (NS003) and IV Administration in Healthy Adults | Nasus Pharma | Phase 1 | Recruiting | Chemotherapy-Induced Nausea and Vomiting (CINV), Radiotherapy-induced Nausea and Vomiting (RINV), Postoperative Nausea... | 12 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07868861) |
| October 6, 2026 | NCT07861100 | A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Cardiovascular Risk, Obesity | 8,500 | Argentina, Australia, Brazil, Bulgaria, Canada, China, Czechia, Denmark... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07861100) |
| October 5, 2026 | NCT07858903 | Initial Safety and Preliminary Efficacy of the Novelrad Vascular Closure System (NVCS) | Novelrad Ltd. | Not applicable | Completed | Vascular Closure Device, Femoral Arteriotomy Closure, Femoral Access Site Closure | 15 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07858903) |
| October 5, 2026 | NCT07856940 | GPT-Based Digital Assistant Support During Treatment for Induced Abortion or Missed Abortion | Wolfson Medical Center | Not applicable | Not yet recruiting | Missed Abortion, Early Pregnancy Loss, Abortion in First Trimester, Abortion, Medical | 100 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07856940) |
| October 1, 2026 | NCT07851558 | Early Mobilization and No Urinary Catheter After Cesarean for Improved Post Operative Recovery: A Randomized Trial | Bnai Zion Medical Center | Not applicable | Completed | Postoperative Care | 260 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07851558) |
| October 1, 2026 | NCT07851272 | Internal Versus External Attentional Focus in Gross- and Fine-Motor Learning Among Children With Autism Requiring Ongoing Everyday Support | University of Haifa | Not applicable | Completed | ASD | 10 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07851272) |
| October 1, 2026 | NCT07851025 | Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Non-Homologous Recombination Deficiency (Non-HRD) Positive Advanced... | AstraZeneca | Phase 3 | Recruiting | Epithelial Ovarian Cancer | 950 | Argentina, Australia, Brazil, Bulgaria, Canada, Chile, China, Colombia... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07851025) |
| September 30, 2026 | NCT07850765 | Real-World Patient and Physician Experience With Semaglutide Across Six Emerging Markets | Novo Nordisk A/S | Observational | Completed | Overweight, Obesity | 1,260 | Israel, Mexico, Saudi Arabia, South Africa, Turkey (Türkiye), United Arab... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07850765) |
| September 25, 2026 | NCT07841509 | The Effect of Remote Electrical Neuromodulation (REN) on Conditioned Pain Modulation (CPM) in Migraine and Fibromyalgia | Theranica | Not applicable | Recruiting | Migraine, Fibromyalgia, Conditioned Pain Modulation | 120 | Israel, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07841509) |
| September 24, 2026 | NCT07839559 | Disability Trajectories After Occupational Injury | Sergio Gabriel Susmallian | Observational | Completed | Occupational Injury, Work-Related Disability | 1,500,000 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07839559) |
| September 23, 2026 | NCT07836348 | A Closed Unit Incorporating Soteria Elements Versus a Conventional Closed Psychiatric Ward | Jerusalem Mental Health Center | Not applicable | Recruiting | Psychotic Disorders | 200 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07836348) |
| September 21, 2026 | NCT07831213 | Post-Market Clinical Follow-up (PMCF) Study of Safety and Performance of 300-01 RefillHA Lips | Glyance | Observational | Recruiting | Mild Defects of the Lips | 87 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07831213) |
| September 21, 2026 | NCT07831083 | Skin Cancer Among Outdoor Workers | Assuta Medical Center | Observational | Completed | Melanoma (Skin Cancer), Basal Cell Carcinoma of Skin, Squamous Cell Cancer of Head and Neck (SCCHN), Work Injury, Sun... | 10,000 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07831083) |
| September 21, 2026 | NCT07831005 | Occupational Claims Due to Hernia | Sergio Gabriel Susmallian | Observational | Completed | Hernia, Hernia Abdominal Wall, Hernia Incisional | 4,500 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07831005) |
| September 18, 2026 | NCT07828106 | Feasibility and Effectiveness of Tele-diabetes Remote System on Glycemic Control and Quality of Life of Children and Youth With Type 1... | Sheba Medical Center | Not applicable | Recruiting | Diabetes Mellitus, Type 1 Diabetes, Mobile Health Platform, Mobile Health Technology (mHealth), Mobile Health... | 100 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07828106) |
| September 17, 2026 | NCT07826533 | Intravenous Papaverine for Term Prelabor Rupture of Membranes | Wolfson Medical Center | Not applicable | Recruiting | Premature Rupture of Fetal Membranes | 200 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07826533) |
| September 16, 2026 | NCT07823517 | LLM-Generated Medical Summaries During Hospitalization to Improve Patient Activation in High-Risk Pregnancies | Sheba Medical Center | Not applicable | Not yet recruiting | High-risk Pregnancy, Hospitalization, Patient Activation, Artificial Intelligence (AI) | 200 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07823517) |
| September 15, 2026 | NCT07820670 | Rivaroxaban vs Enoxaparin After Cesarean Section: Laboratory Thromboprophylaxis Outcomes | Wolfson Medical Center | Not applicable | Recruiting | Postpartum Period, Cesarean Section Surgery, VTE (Venous Thromboembolism) | 62 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07820670) |
| September 14, 2026 | NCT07817875 | Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12... | Eli Lilly and Company | Phase 3 | Recruiting | Obesity | 150 | Belgium, Israel, Italy, Mexico, Poland, Portugal, South Korea, Spain, Taiwan... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07817875) |
| September 11, 2026 | NCT07816393 | Virtual Reality for Pain and Anxiety During HyFoSy | HaEmek Medical Center, Israel | Not applicable | Not yet recruiting | Infertility | 68 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07816393) |
| September 9, 2026 | NCT07808983 | Chewing, Eating Rate, and Weight Status in Children | Ariel University | Not applicable | Recruiting | Healhty | 70 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07808983) |
| September 9, 2026 | NCT07808892 | Ultra-Processing and Nutritional Quality: Glycemic Response, Appetite, Dietary Energy Intake, and Eating Rate | Ariel University | Not applicable | Recruiting | Eating, Anxiety, Ultra Processed Food | 40 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07808892) |
| September 2, 2026 | NCT07800663 | Sensory Hyperstimulation for Treating Depression | Shalvata Mental Health Center | Not applicable | Completed | Depressive Disorder | 15 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07800663) |
| September 1, 2026 | NCT07798687 | The Growing Burden of Hearing-Related Disability. | Assuta Medical Center | Observational | Completed | Hearing Loss, Noise-Induced | 150,000 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07798687) |
| August 28, 2026 | NCT07789483 | An Open-Label Study to Evaluate the Long-Term Safety and Efficacy of ALXN2220 in Adults With Transthyretin Amyloid Cardiomyopathy | Alexion Pharmaceuticals, Inc. | Phase 3 | Not yet recruiting | Transthyretin Amyloid Cardiomyopathy (ATTR-CM) | 1,180 | Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Czechia... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07789483) |
| August 27, 2026 | NCT07791303 | Safety, Tolerability and Pharmacokinetics of Oral Ketamir-2 in Healthy Adult Subjects | MIRA Pharmaceuticals | Phase 1 | Completed | Healthy Adult Participants | 57 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07791303) |
| August 27, 2026 | NCT07790588 | Project Leo: Trauma-Informed Yoga for Preschool Children and Parents | Florida Atlantic University | Not applicable | Not yet recruiting | Post Traumatic Concerns | 66 | Israel, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07790588) |
| August 26, 2026 | NCT07788235 | Diabetes and Permanent Disabilities | Assuta Medical Center | Observational | Completed | Diabetes, Diabetes (Insulin-requiring, Type 1 or Type 2) | 450,000 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07788235) |
| August 24, 2026 | NCT07782073 | Comparison Between Paravertebral and Erector Spinal Block Efficacy in Robotic Thoracic Surgeries | Soroka University Medical Center | Not applicable | Active not recruiting | Post Operative Analgesia, Regional Anaesthesia, Pain After Surgery, Opioid Consumption | 60 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07782073) |
| August 20, 2026 | NCT07777939 | TENS Use for Post-cesarean Pain Management | Holy Family Hospital, Nazareth, Israel | Not applicable | Not yet recruiting | Post Cesarean Pain Management | 196 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07777939) |
| August 20, 2026 | NCT07777744 | Severe Complications During Ventricular Tachycardia or Premature Ventricular Complex Ablation | University Hospital, Basel, Switzerland | Observational | Recruiting | Ventricular Tachycardia (VT), Premature Ventricular Complexes | 15,000 | Austria, Canada, China, Croatia, France, Germany, Greece, Israel, Italy... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07777744) |
| August 20, 2026 | NCT07776691 | A Study of Raludotatug Deruxtecan With or Without Bevacizumab as First-Line Maintenance Treatment in Non-HRD-Positive Advanced Ovarian... | Merck Sharp & Dohme LLC | Phase 3 | Recruiting | Ovarian Cancer, Ovarian Neoplasms, Peritoneal Cancer, Fallopian Tube Cancer | 802 | Israel, South Korea, Taiwan, United Kingdom, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07776691) |
| August 20, 2026 | NCT07776509 | A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With... | AstraZeneca | Phase 3 | Recruiting | Obesity or Overweight, Weight-Related Comorbidity, With/Without Diabetes Mellitus, Type 2 | 500 | Argentina, Brazil, Canada, China, Denmark, Israel, Japan, Sweden, Turkey... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07776509) |
| August 20, 2026 | NCT07776184 | Multi-Component Delirium Prevention Bundle in Older Cardiac Intensive Care Unit Patients | Tel Aviv Medical Center | Not applicable | Active not recruiting | Delirium in Old Age, Delirium in the Intensive Care Unit, Delirium Confusional State, Delirium, Cardiac Intensive Care... | 200 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07776184) |
| August 20, 2026 | NCT07775339 | Long-Term Efficacy and Safety of Lerodalcibep in Children and Adolescents With Familial Hypercholesterolemia | LIB Therapeutics LLC | Phase 3 | Not yet recruiting | Heterozygous Familial Hypercholesterolemia (HeFH) | 150 | India, Israel, New Zealand, South Africa, Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07775339) |
| August 18, 2026 | NCT07771530 | The Efficacy of a Pharmacological Treatment (Reboxetine Plus Ritalin) Versus Dog-Assisted Therapy in PTSD | University of Haifa | Phase 2 | Recruiting | PTSD, Posttraumatic Stress Disorder | 160 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07771530) |
| August 18, 2026 | NCT07770607 | Assessing the Level of Awareness Regarding the Unique Medical Needs of the LGBTQ+ Community Among Emergency Department Physicians, as Well... | Barzilai Medical Center | Not applicable | Not yet recruiting | LGBTQ | 500 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07770607) |
| August 18, 2026 | NCT07769502 | A Study to Assess Adverse Events and Change in Disease Activity With Treatment Combinations With Telisotuzumab Adizutecan in Adults... | AbbVie | Phase 2 | Recruiting | Pancreatobiliary Cancers, Pancreatic Ductal Adenocarcinoma | 168 | Israel, Japan, Taiwan, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07769502) |
| August 17, 2026 | NCT07767019 | Climate Change Trends and Their Impact on the Seasonal Upper Respiratory Tract Disease Burden | Barzilai Medical Center | Observational | Not yet recruiting | Upper Resp Tract Infection | 5,000 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07767019) |
| August 13, 2026 | NCT07764068 | Targeted Deep Pelvic Floor Muscle Physiotherapy Versus Antenatal Perineal Massage in Nulliparous Women | Meir Medical Center | Not applicable | Completed | Perineal Injury, Perineal Laceration, Tear, or Rupture During Delivery | 50 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07764068) |
| August 13, 2026 | NCT07763990 | THE EVALUATION OF THE SAFETY AND PERFORMANCE OF AN INJECTABLE HYALURONIC ACID FILLER | Hallura Ltd. | Not applicable | Recruiting | Lips Enhancement Nasolabial Fold Correction Midface Volume Deficit | 98 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07763990) |
| August 13, 2026 | NCT07762534 | Physician vs Artificial Intelligence Counseling Before Elective Cesarean Delivery: A Randomized Controlled Trial | Wolfson Medical Center | Not applicable | Not yet recruiting | Cesarean Section, Informed Consent, Anxiety | 50 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07762534) |
| August 12, 2026 | NCT07759895 | Combination Therapy of Deferiprone and N-Acetylcysteine for Treating Negative Symptoms in Schizophrenia | Amit Lotan | Phase 2 | Recruiting | Schizoaffecitve Disorder, Schizophrenia and Schizoaffective Disorder, Schizophrenia and Predominant Negative Symptoms | 80 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07759895) |
| August 12, 2026 | NCT07759193 | Energy Expenditure Assessment in Head and Neck Cancer Patients Treated With Free Flap Surgery | Tel-Aviv Sourasky Medical Center | Not applicable | Recruiting | Reconstructive Surgical Procedures, Free Tissue Flaps, Head and Neck Cancer, Perioperative Care | 19 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07759193) |
| August 10, 2026 | NCT07753993 | A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease. | AstraZeneca | Phase 3 | Recruiting | Chronic Kidney Disease | 7,000 | Argentina, Australia, Brazil, Bulgaria, Canada, Chile, China, Czechia, Denmark... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07753993) |
| August 6, 2026 | NCT07750782 | Environmental and Geographic Patterns of Occupational Injuries | Sergio Gabriel Susmallian | Observational | Active not recruiting | Occupational Accidents, Weather | 350,000 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07750782) |
| August 5, 2026 | NCT07746713 | A Study of JNJ-98768111 in Participants With Advanced Prostate Cancer | Janssen Research & Development, LLC | Phase 1 | Recruiting | Prostatic Neoplasms | 160 | Israel, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07746713) |
| August 5, 2026 | NCT07746687 | A Study of JNJ-95597528 in Participants With Inadequately Controlled Moderate to Severe Asthma | Janssen Research & Development, LLC | Phase 2 | Recruiting | Asthma | 440 | Argentina, China, Israel, Japan, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07746687) |
| August 4, 2026 | NCT07745647 | Voll Non-Degradable Shoulder Spacer FIH Study | Voll Medical Technologies Ltd. | Not applicable | Not yet recruiting | Massive Rotator Cuff Tears, Massive Rotator Cuff Tear | 10 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07745647) |
| August 4, 2026 | NCT07744984 | The Efficacy of Home OCT Supported Management in Patients Diagnosed With Neovascular-AMD and Undergoing a Drug Switch to Faricimab | Rabin Medical Center | Observational | Completed | Age-Related Macular Degeneration (AMD), Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD | 12 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07744984) |
| August 3, 2026 | NCT07743164 | A Clinical Trial of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab in Participants With Ovarian Cancer Who Have Progressed... | Merck Sharp & Dohme LLC | Phase 3 | Recruiting | Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer | 646 | Israel, Taiwan, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07743164) |
| August 3, 2026 | NCT07742735 | A Study to Investigate the Efficacy and Safety of Apraglutide Compared With Placebo in Adult Participants With Short Bowel Syndrome... | VectivBio AG | Phase 3 | Recruiting | Short Bowel Syndrome (SBS), SBS Associated With Intestinal Failure (SBS-IF) | 124 | Argentina, Australia, Austria, Belgium, Brazil, Canada, Czechia, Denmark... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07742735) |
| July 31, 2026 | NCT07740629 | Does Use of a Pre-Procedure Educational Video for Urodynamic Testing Reduces Anxiety? | Yair Daykan | Not applicable | Recruiting | Urinary Incontinence, Urinary Bladder Overactive, Urinary Incontinence , Stress | 60 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07740629) |
| July 31, 2026 | NCT07738562 | Dipyridamole for Early-Onset Preeclampsia: A Pilot Study of Feasibility, Pharmacokinetics, and Biological Effects | Hadassah Medical Organization | Phase 1/2 | Not yet recruiting | Preeclampsia (PE), Hypertension ,Pregnancy | 15 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07738562) |
| July 30, 2026 | NCT07737743 | A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease | Novartis Pharmaceuticals | Phase 2 | Recruiting | Sjögren's Disease | 344 | Australia, Canada, China, Colombia, France, Hungary, Israel, Netherlands... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07737743) |
| July 30, 2026 | NCT07737054 | Trauma-informed Psilocybin Assisted Psychotherapy (TiPAP) for PTSD | Tel-Aviv Sourasky Medical Center | Early phase 1 | Recruiting | Post-Traumatic Stress Disorder, PTSD | 13 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07737054) |
| July 30, 2026 | NCT07736703 | A Clinical Investigation Comparing the Safety and Performance of RefillHA Solid With Hydryalix Ultra Deep Lidocaine for the Correction of... | Glyance | Observational | Completed | Wrinkles, Folds | 12 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07736703) |
| July 28, 2026 | NCT07732062 | vEAET-H for Chronic Pain Patients Using Medical Cannabis in Israel - A Feasibility Study | Reuth Rehabilitation Hospital | Not applicable | Recruiting | Chronic Musculoskeletal Pain, Cannabis Use | 42 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07732062) |
| July 28, 2026 | NCT07730931 | Forced Oscillatory Technique for Bronchiolitis Obliterans Syndrome After Allogeneic Bone Marrow Transplantation | Hadassah Medical Organization | Not applicable | Recruiting | Bronchiolitis Obliterable Syndrome | 400 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07730931) |
| July 27, 2026 | NCT07729462 | A Study to Learn About the Study Medicine Called Rimegepant in Adults When Used for the Prevention of Chronic Migraine | Pfizer | Phase 3 | Recruiting | Preventive Treatment of Migraine | 400 | Israel, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07729462) |
| July 27, 2026 | NCT07728474 | LCS103 Herbal Formula for Secondary Prevention of Non-Muscle Invasive Urothelial Carcinoma of the Bladder | LifeBiotic Medical Research Ltd. | Not applicable | Recruiting | Non-muscle Invasive Bladder Cancer (NMIBC) | 60 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07728474) |
| July 24, 2026 | NCT07726316 | An Observational Study Measuring in a Non-invasive Approach the Nociception Level Index and Its Association With Pain and Anxieiy... | Michael Grach | Observational | Not yet recruiting | Cesarean Delivery | 100 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07726316) |
| July 24, 2026 | NCT07725237 | Single Photon Emission Computed Tomography/Computed Tomography (SPECT/CT) Prospective Double-Scanning Study | GE Healthcare | Observational | Recruiting | SPECT-CT | 30 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07725237) |
| July 24, 2026 | NCT07724808 | Rewiring Chronic Pain | Ben-Gurion University of the Negev | Not applicable | Not yet recruiting | Full PRT, Partial PRT (Non Somtic), Treatment as Usual | 150 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07724808) |
| July 23, 2026 | NCT07722611 | A Clinical Trial of Bomedemstat in Participants With Polycythemia Vera (MK-3543-025). | Merck Sharp & Dohme LLC | Phase 2/3 | Recruiting | Polycythemia Vera | 380 | Canada, Israel, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07722611) |
| July 22, 2026 | NCT07720674 | SEE FAR CBT Intervention for Adults With PTSD | Community Stress Prevention Center | Not applicable | Recruiting | Post Traumatic Stress Disorder | 60 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07720674) |
| July 20, 2026 | NCT07714902 | Administration Of Calcium Gluconate for The Reduction of Blood Loss During Vaginal Delivery | Rambam Health Care Campus | Not applicable | Recruiting | Postpartum Hemorrhage | 710 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07714902) |
| July 17, 2026 | NCT07710573 | Brief SEE FAR CBT Intervention Compared With Treatment as Usual for Adults With PTSD | Community Stress Prevention Center | Not applicable | Recruiting | Post Traumatic Stress Disorder | 60 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07710573) |
| July 16, 2026 | NCT07709000 | A Clinical Trial of MK-1045 in People With B-cell Cancer (MK-1045-006) | Merck Sharp & Dohme LLC | Phase 2 | Recruiting | Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma, Hematologic Malignancies | 60 | Colombia, Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07709000) |
| July 16, 2026 | NCT07707921 | Pilot Clinical Trial of Ultrasound Guided Aortic Compression for Arresting Abdominal Aortic Blood Flow in Healthy Volunteers. This Isn't... | Tel-Aviv Sourasky Medical Center | Not applicable | Not yet recruiting | Healthy Volunteers | 20 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07707921) |
| July 16, 2026 | NCT07707765 | The Effect of Early Intervention on the Incidence of Posttraumatic Stress Disorder After Intensive Care Hospitalization Due to Sepsis | Barzilai Medical Center | Not applicable | Recruiting | PTSD - Post Traumatic Stress Disorder, Sepsis, ICU | 60 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07707765) |
| July 16, 2026 | NCT07707648 | Evaluation of the Feasibility and Safety of ENCER for Cancer Treatment-Related Fatigue in Patients Receiving Chemotherapy or Radiotherapy | Beaura for Para Pharmaceutical Products Trading LLC | Early phase 1 | Completed | Fatigue Related to Cancer Treatment | 62 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07707648) |

## Sponsors posting most

| Sponsor | New trials | Latest |
| --- | --- | --- |
| Merck Sharp & Dohme LLC | 48 | August 20, 2026 |
| Tel-Aviv Sourasky Medical Center | 29 | November 3, 2026 |
| Sheba Medical Center | 24 | November 3, 2026 |
| AbbVie | 21 | August 18, 2026 |
| Janssen Research & Development, LLC | 20 | October 30, 2026 |
| AstraZeneca | 19 | October 1, 2026 |
| Tel Aviv University | 18 | June 24, 2026 |
| Sanofi | 17 | February 17, 2026 |
| University of Haifa | 16 | November 3, 2026 |
| Hadassah Medical Organization | 16 | November 3, 2026 |
| Assaf-Harofeh Medical Center | 16 | October 16, 2026 |
| Eli Lilly and Company | 16 | September 14, 2026 |
| Pfizer | 16 | July 27, 2026 |
| Rabin Medical Center | 15 | August 4, 2026 |
| Wolfson Medical Center | 14 | October 16, 2026 |
| Novartis Pharmaceuticals | 13 | July 30, 2026 |
| Hillel Yaffe Medical Center | 12 | April 15, 2026 |
| Meir Medical Center | 11 | October 23, 2026 |
| Bristol-Myers Squibb | 11 | March 2, 2026 |
| Barzilai Medical Center | 8 | August 18, 2026 |

## Conditions

| Condition group | New trials | Latest |
| --- | --- | --- |
| [Neoplasms](https://specstream.ai/data/clinical-trials/condition/neoplasms) | 24 | August 18, 2026 |
| [Carcinoma, Non-Small-Cell Lung](https://specstream.ai/data/clinical-trials/condition/carcinoma-non-small-cell-lung) | 21 | April 7, 2026 |
| [Obesity](https://specstream.ai/data/clinical-trials/condition/obesity) | 15 | October 6, 2026 |
| [Colitis, Ulcerative](https://specstream.ai/data/clinical-trials/condition/colitis-ulcerative) | 15 | July 13, 2026 |
| [Breast Neoplasms](https://specstream.ai/data/clinical-trials/condition/breast-neoplasms) | 13 | October 26, 2026 |
| [Stress Disorders, Post-Traumatic](https://specstream.ai/data/clinical-trials/condition/stress-disorders-post-traumatic) | 13 | October 19, 2026 |
| [Multiple Myeloma](https://specstream.ai/data/clinical-trials/condition/multiple-myeloma) | 13 | October 14, 2026 |
| [Diabetes Mellitus, Type 1](https://specstream.ai/data/clinical-trials/condition/diabetes-mellitus-type-1) | 13 | September 18, 2026 |
| [Lung Neoplasms](https://specstream.ai/data/clinical-trials/condition/lung-neoplasms) | 12 | June 9, 2026 |
| [Crohn Disease](https://specstream.ai/data/clinical-trials/condition/crohn-disease) | 11 | July 13, 2026 |
| [Anxiety Disorders](https://specstream.ai/data/clinical-trials/condition/anxiety-disorders) | 10 | November 2, 2026 |
| [Prostatic Neoplasms](https://specstream.ai/data/clinical-trials/condition/prostatic-neoplasms) | 10 | October 30, 2026 |
| [Ovarian Neoplasms](https://specstream.ai/data/clinical-trials/condition/ovarian-neoplasms) | 9 | August 20, 2026 |
| [Pulmonary Disease, Chronic Obstructive](https://specstream.ai/data/clinical-trials/condition/pulmonary-disease-chronic-obstructive) | 9 | June 24, 2026 |
| [Heart Failure](https://specstream.ai/data/clinical-trials/condition/heart-failure) | 9 | May 22, 2026 |
| [Overweight](https://specstream.ai/data/clinical-trials/condition/overweight) | 8 | September 30, 2026 |
| [Lupus Erythematosus, Systemic](https://specstream.ai/data/clinical-trials/condition/lupus-erythematosus-systemic) | 8 | June 5, 2026 |
| [Agnosia](https://specstream.ai/data/clinical-trials/condition/agnosia) | 8 | April 17, 2026 |
| [Neoplasm Metastasis](https://specstream.ai/data/clinical-trials/condition/neoplasm-metastasis) | 8 | October 30, 2025 |
| [Suicidal Ideation](https://specstream.ai/data/clinical-trials/condition/suicidal-ideation) | 7 | November 3, 2026 |
| [Pain](https://specstream.ai/data/clinical-trials/condition/pain) | 7 | November 2, 2026 |
| [Urinary Bladder Neoplasms](https://specstream.ai/data/clinical-trials/condition/urinary-bladder-neoplasms) | 7 | October 19, 2026 |
| [Stroke](https://specstream.ai/data/clinical-trials/condition/stroke) | 7 | July 8, 2026 |
| [Depression](https://specstream.ai/data/clinical-trials/condition/depression) | 6 | November 6, 2026 |
| [Parkinson Disease](https://specstream.ai/data/clinical-trials/condition/parkinson-disease) | 6 | October 30, 2026 |

## By phase

| Phase | New trials | Latest |
| --- | --- | --- |
| [Not applicable](https://specstream.ai/data/clinical-trials/phase/not-applicable) | 214 | November 6, 2026 |
| [Phase 3](https://specstream.ai/data/clinical-trials/phase/phase-3) | 163 | November 4, 2026 |
| [Observational](https://specstream.ai/data/clinical-trials/phase/observational) | 129 | November 6, 2026 |
| [Phase 2](https://specstream.ai/data/clinical-trials/phase/phase-2) | 71 | October 26, 2026 |
| [Phase 1/2](https://specstream.ai/data/clinical-trials/phase/phase-1-2) | 36 | October 13, 2026 |
| [Phase 1](https://specstream.ai/data/clinical-trials/phase/phase-1) | 28 | October 19, 2026 |
| [Phase 2/3](https://specstream.ai/data/clinical-trials/phase/phase-2-3) | 25 | July 23, 2026 |
| [Phase 4](https://specstream.ai/data/clinical-trials/phase/phase-4) | 17 | June 24, 2026 |
| [Early phase 1](https://specstream.ai/data/clinical-trials/phase/early-phase-1) | 5 | July 30, 2026 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it.

Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).